Clearance Summary
Levo Gen 2 Tinnitus Therapy System received FDA 510(k) clearance under submission number K260413, sponsored by Levo Medical Corporation. The device was reviewed via the Traditional premarket notification pathway and assigned to the Ear, Nose, Throat review panel. The statutory decision date of record is 2026-08-13.
- Submission: K260413
- Applicant / Sponsor: Levo Medical Corporation
- Clearance pathway: Traditional
- Review panel: Ear, Nose, Throat
- Device class: Class II
- Regulation citation: 21 CFR 874.3400
- Decision date: 2026-08-13
Classification & Regulation
This clearance is catalogued under FDA product code KLW and 21 CFR 874.3400, within the Ear, Nose, Throat review panel as a Class II device.